Pular para o conteúdo
Equinococose alveolar
ORPHA:284CID-10 · B67.6CID-11 · 1F73.YDOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
kidneyInício adultaHerança Unknown
Também conhecida comoEA

A equinococose alveolar (EA) é uma doença parasitária rara que ocorre após a ingestão de ovos de Echinococcus multilocularis. A EA é caracterizada por um período inicial de incubação assintomático de muitos anos seguido por um curso crônico onde as manifestações clínicas incluem dor epigástrica e icterícia.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A equinococose alveolar é uma doença rara decorrente da infecção por ovos do parasita *Echinococcus multilocularis*. Ela permanece sem sintomas por muitos anos, mas depois pode provocar dores no estômago, cansaço e **icterícia** (pele e olhos amarelados). No Brasil, a condição ainda não possui um Protocolo Clínico e Diretrizes Terapêuticas (PCDT) formulado pelo Ministério da Saúde. O acompanhamento das lesões no fígado e demais sintomas deve ser realizado pela rede assistencial do SUS com base no julgamento clínico da equipe médica.

📋
Informacoes curadas por IA — podem conter imprecisoes

A equinococose alveolar (EA) é uma doença parasitária rara que ocorre após a ingestão de ovos de Echinococcus multilocularis. A EA é caracterizada por um período inicial de incubação assintomático de muitos anos seguido por um curso crônico onde as manifestações clínicas incluem dor epigástrica e icterícia.

Publicações científicas
2.187 artigos
Último publicado: 2026 Apr 16

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Adult
+ elderly
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: B67.6
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
7 sintomas
🧠
Neurológico
4 sintomas
🫁
Pulmão
3 sintomas
🫘
Rins
3 sintomas
🩸
Sangue
3 sintomas
🦴
Ossos e articulações
3 sintomas

+ 23 sintomas em outras categorias

Características mais comuns

90%prev.
Aumento do nível circulante de anticorpos
Muito frequente (99-80%)
90%prev.
Cistos hepáticos
Muito frequente (99-80%)
90%prev.
Taxa de sedimentação de eritrócitos elevada
Muito frequente (99-80%)
90%prev.
Eosinofilia
Muito frequente (99-80%)
55%prev.
Dor lombar
Frequente (79-30%)
55%prev.
Dor epigástrica
Frequente (79-30%)
50sintomas
Muito frequente (4)
Frequente (10)
Ocasional (14)
Muito raro (22)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 50 características clínicas mais associadas, ordenadas por frequência.

Aumento do nível circulante de anticorposIncreased circulating antibody level
Muito frequente (99-80%)90%
Cistos hepáticosHepatic cysts
Muito frequente (99-80%)90%
Taxa de sedimentação de eritrócitos elevadaElevated erythrocyte sedimentation rate
Muito frequente (99-80%)90%
EosinofiliaEosinophilia
Muito frequente (99-80%)90%
Dor lombarLow back pain
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico2.187PubMed
Últimos 10 anos200publicações
Pico2025142 papers
Linha do tempo
2026Hoje · 2026🧪 1992Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 4 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Equinococose alveolar

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Nenhum país com ensaio aberto no momento.

Pesquisa e ensaios clínicos

4 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.148 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.148

#1

Detection of Echinococcus multilocularis in coyotes in Washington State, USA highlights need for increased wildlife surveillance.

PLoS neglected tropical diseases2026 Mar

Echinococcus multilocularis is a zoonotic cestode that uses canids as definitive hosts and rodents as intermediate hosts. In humans, this parasite is the causative agent of alveolar echinococcosis. Recently, its range has been expanding across the Northern Hemisphere, and it is increasingly detected in wild canids, domestic dogs, and humans across Canada and the United States. While this expansion has been documented in isolated studies across the continent, a lack of routine sampling in wildlife hinders our ability to anticipate and mitigate further spread of E. multilocularis. We confirmed the presence of E. multilocularis in Washington State, USA, using a combination of morphological and molecular techniques across carcasses and field-collected scats of coyotes (Canis latrans), this region's most common wild canid. Morphological identification of adult worms was confirmed by next-generation sequencing. Over a third of all samples tested positive for E. multilocularis when all methodologies were combined. Sequencing revealed a haplotype of E. multilocularis matching a documented haplotype originally of European origin in British Columbia, Canada. Our study provides the first confirmation of E. multilocularis in a wild host on the west coast of the contiguous United States and provides additional haplotype information crucial to tracking the geographical expansion of the parasite. We also provide a new next-generation sequencing primer targeting cestodes of canids. The difference in amplification between intestinal and fecal samples suggests that non-invasive fecal sampling using DNA metabarcoding - a popular method of helminth surveillance - may lead to underestimation of prevalence, hindering control measures. The global significance of these findings extends beyond North America; E. multilocularis is a major public health concern in Europe and Asia, where alveolar echinococcosis is increasingly diagnosed in humans. Our study highlights the urgent need for increased surveillance and improved diagnostic strategies worldwide, particularly in regions with significant human-wildlife contact.

#2

Canonical WNT signalling governs Echinococcus metacestode development.

PLoS pathogens2026 Mar 23

Alveolar echinococcosis (AE) is a lethal zoonosis caused by infiltrative growth of the metacestode larva of the tapeworm Echinococcus multilocularis in host organs. We previously showed that the Echinococcus metacestode is an evolutionarily unique, broadly posteriorized tissue, leading us to hypothesize that canonical WNT (cWNT) signalling, which patterns the body axis across metazoans, might be critical for metacestode formation. Here, we report effective RNAi-mediated knockdown of the E. multilocularis β-catenin gene (bcat-1), the central effector of cWNT signalling, in a primary parasite cell culture system that produces metacestode vesicles. bcat-1(RNAi) cultures were markedly impaired in vesicle formation, exhibited stem-cell hyperproliferation, and displayed changes in muscle-fibre organisation. Genome-wide transcriptomics revealed a general anteriorization of gene expression, and in situ hybridization showed an overproduction of cells expressing head-inducing factors such as sfrp upon bcat-1 knockdown. Conversely, metacestode-specific genes including the tegumental factors muc-1, TNFR, and antigen B as well as the posterior marker post2b were significantly downregulated, consistent with the observed vesicle-formation defects. In situ analyses further identified anterior markers frizzled-10, nou-darake, notum, and follistatin that were overexpressed in bcat-1(RNAi) cultures and localized to the future anterior pole at the earliest stages of protoscolex formation. Together, these findings establish a central role for cWNT signalling in directing Echinococcus body-axis formation and the posteriorization events driving metacestode growth within the host, providing insight into asexual parasite proliferation mediated by this biologically unique larval stage and pointing to potential targets for chemotherapy against AE.

#3

Burden of cystic and alveolar echinococcosis in the Kyrgyz Republic.

PLoS neglected tropical diseases2026 Mar 23

The purpose of this study is to assess some aspects of the burden of cystic and alveolar echinococcosis in the Kyrgyz Republic. From 2015-2020 a total of 5568 cases of primary cystic echinococcosis (CE) were reported and a further 1008 recurrent cases. Over the same time period 880 primary cases of primary alveolar echinococcosis (AE) were reported and a further 343 recurrent cases. The estimated DALYs for CE was 7849, that is 1308 per annum or 19.5 per 100,000 per annum. For AE was there were 3809 DALYs, that is 634 per annum or 9.5 per 100,000 per annum. The proportion of fatal cases of AE was 3.6 times higher than from CE. The total economic damage in terms of purchasing power equivalent (PPE) from CE amounted to more than 10,5 million international US dollars. For AE it amounted to more than 5.1 million international US dollars. Most of the financial burden falls on the patients themselves and amounts to 68.4%, i.e., 1223 PPE dollars per case out of total spending 1615 PPE dollars per case. To reduce the social and economic burden of echinococcosis, it is necessary to timely identify the disease, prevent the development of complications and multiple lesions, and promote preventive chemotherapy where appropriate. A deep understanding of the etiology, epidemiology, clinical manifestations, and tactics of early diagnosis of various forms of echinococcosis is also important for timely detection, effective control, and, most importantly, the organization of preventive measures to combat this disease.

#4

Population-based ultrasound prevalence and risk factors for cystic echinococcosis in endemic Kazakhstan.

PLoS neglected tropical diseases2026 Mar

Cystic echinococcosis (CE), caused by Echinococcus granulosus sensu lato, remains a significant public health concern in endemic areas of Kazakhstan. Despite global control efforts, CE persists due to insufficient deworming of dogs, the absence of control programs, and low public awareness. A cross-sectional study was conducted between September 2023 and June 2024 in 51 remote villages across two endemic regions of Kazakhstan. Participants underwent abdominal ultrasound screening and completed a structured questionnaire to assess potential risk factors. Cyst staging was performed according to the WHO - Informal Working Group on Echinococcosis guidelines. Statistical analyses included both univariate and multivariate models to identify significant predictors of infection. The prevalence of CE was 0.34%, with higher rates observed in young people (82.1%) than in adults (17.9%), particularly among those aged 9-14 years. Major potential risk factors included dog ownership (OR = 3.17, p = 0.012), failure to deworm dogs (OR = 11.12, p = 0.018), feeding raw offal to dogs (OR = 3.06, p = 0.012), and consumption of unwashed vegetables and fruits among women (OR = 5.25, p = 0.005). All identified CE cases were newly diagnosed. Of these, 92.85% were active cysts, predominantly found in young individuals, while inactive cysts accounted for 7.14%, distributed equally between adults and youths. These findings underscore the urgent need for regular deworming programs for dogs, public education on hygiene practices, and stricter management of livestock offal. Further research is needed to investigate transmission through water and environmental contamination.

#5

A neuregulin-like ligand and EGF receptor underpin Echinococcus multilocularis development.

Frontiers in cellular and infection microbiology2026

Alveolar echinococcosis (AE), a neglected zoonotic disease, is caused by the infiltrative growth of the metacestode larval stage of the cestode Echinococcus multilocularis within host organs. We previously showed that metacestode development relies on the mitotic activity of a population of parasite stem cells known as germinative cells. However, the molecular mechanisms that control Echinococcus stem cell dynamics such as cell-cycle progression, self-renewal, and differentiation remain poorly understood. Building on earlier reports implicating epidermal growth factor (EGF) signalling in stem cell regulation, we here characterize the parasite's repertoire of three EGF receptors. Using RNAi and inhibitor assays, we identify one receptor, EmER1, as essential for the formation of metacestode vesicles from germinative cells. We further demonstrate that EmER1 is targeted by afatinib, an EGF receptor inhibitor with potent anti-parasitic activity both in vitro and in vivo. Through bioinformatic analyses and membrane-bound yeast two-hybrid assays, we identified a parasite-derived, neuregulin-like ligand for EmER1, termed EmNRG, whose expression is strongly upregulated in metacestode vesicles during clonal expansion of germinative cells. RNAi-mediated knockdown of the EmNRG encoding gene severely impaired the capacity of germinative cells to generate metacestode vesicles. Our data support that EmNRG and EmER1 constitute a cognate ligand - receptor system regulating the balance between asymmetric and symmetric stem cell division in E. multilocularis. These findings provide new insights into Echinococcus stem cell biology and highlight EGF signalling as a promising avenue for developing novel anti-echinococcosis therapeutics.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.294 artigos no totalmostrando 198

2026

Detection of Echinococcus multilocularis in coyotes in Washington State, USA highlights need for increased wildlife surveillance.

PLoS neglected tropical diseases
2026

Canonical WNT signalling governs Echinococcus metacestode development.

PLoS pathogens
2026

Burden of cystic and alveolar echinococcosis in the Kyrgyz Republic.

PLoS neglected tropical diseases
2026

Small particles of Echinococcus granulosus (spegs) and Echinococcus multilocularis (spems) promote follicular T helper cell expansion and are associated with IgE and IgG4 class switching in human lymph nodes.

Parasites &amp; vectors
2026

Inflammatory exacerbation of hepatic alveolar echinococcosis during dupilumab therapy: A case report.

IDCases
2026

Analysis of Clinical, Imaging, and Pathological Features of Osseous Echinococcosis.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2026

Population-based ultrasound prevalence and risk factors for cystic echinococcosis in endemic Kazakhstan.

PLoS neglected tropical diseases
2026

A case of left adrenal echinococcosis misdiagnosed as a left renal cyst: Case report.

Medicine
2026

A neuregulin-like ligand and EGF receptor underpin Echinococcus multilocularis development.

Frontiers in cellular and infection microbiology
2026

Alveolar echinococcosis drives functional reprogramming of hepatic CD8+ T cells.

Frontiers in cellular and infection microbiology
2026

CCR8 orchestrates an immunosuppressive niche in the liver to promote Echinococcus multilocularis infection.

PLoS neglected tropical diseases
2026

Alveolar Echinococcosis in the Early 2020s: A Systematic Review.

Pathogens (Basel, Switzerland)
2026

Contrast-Enhanced Ultrasound Phenotypes in Hepatic Alveolar Echinococcosis: Pathological Correlations and Prediction of Vascular Invasion.

Academic radiology
2026

Transplantation as a treatment option for hepatic echinococcosis past, present, and future - a pooled data analysis of 476 patients.

International journal of surgery (London, England)
2026

Euro-Asian hybrids of Echinococcus multilocularis from red foxes in northern and northeastern Poland result from secondary contact between long-isolated populations.

Scientific reports
2026

Protoscolex Maturation in Echinococcus multilocularis Is Controlled by Host Genetic Factors Independent of Initial Development.

Parasite immunology
2026

[Alveolar echinococcosis in a pregnant bitch - a case report].

Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere
2026

LAG3 constrains anti-parasitic response by effector CD4+ T-cell in early Echinococcus multilocularis-infected mice.

Parasites &amp; vectors
2026

Surgical approaches for complex hepatic and perihepatic tumors: a single-center experience with ante situm and ex situ techniques.

International journal of surgery (London, England)
2026

Preparation and MR Imaging Study of a Recombinant Surface Antibody Superparamagnetic Iron Oxide Nanoparticle-EPC1 Molecular Probe for Hepatic Alveolar Echinococcosis.

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine
2026

Hepatic Alveolar Echinococcosis Mimicking Hepatic Malignancy.

Revista da Sociedade Brasileira de Medicina Tropical
2026

Diffuse Pericardial and Diaphragmatic Involvement of Alveolar Echinococcosis in a Liver-Transplanted Patient.

Revista da Sociedade Brasileira de Medicina Tropical
2026

Primary Alveolar Echinococcosis of the Kidney.

Revista da Sociedade Brasileira de Medicina Tropical
2026

A fatal case of complex hepatic alveolar echinococcosis.

Parasites, hosts and diseases
2026

A Multicenter Retrospective Study of Cystic and Alveolar Echinococcosis Patients in the United States (1997-2024).

The American journal of tropical medicine and hygiene
2025

Diagnosis and treatment of hepatic hilar lymph node metastasis in hepatic alveolar echinococcosis patients: a real-world single-center experience.

Frontiers in oncology
2026

The gut microbiota mediates depression-like behaviors in mice with chronic Echinococcus multilocularis infection.

NPJ biofilms and microbiomes
2026

Macrophage-derived S100A9 drives liver fibrosis in Echinococcus multilocularis infection by up-regulating secreted protein acidic and rich in cysteine (SPARC) in hepatic stellate cells.

International journal of biological macromolecules
2026

Exploring the Potential Role of Interleukin-33 in Inducing Eosinophil-Mediated Fibrosis in Hepatic Alveolar Echinococcosis.

Frontiers in bioscience (Landmark edition)
2025

Tapeworms in an Apex Predator: First Molecular Identification of Taenia krabbei and Taenia hydatigena in Wolves (Canis lupus) from Romania.

Pathogens (Basel, Switzerland)
2026

Core-shell heterostructured nanozyme for alveolar echinococcosis treatment via targeted electron transfer and catalytic reactive oxygen species generation.

Journal of colloid and interface science
2026

Analysis of Echinococcus multilocularis complete mitogenomes: evidence for the historical spread from Central Asia to the Northern Hemisphere.

International journal for parasitology
2026

Transformer-based multimodal fusion model predicts lymph node metastasis in hepatic alveolar echinococcosis patients: A multicenter study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2025

IL-22-STAT3-CD155 axis in alveolar echinococcosis: a pivotal role in immune exhaustion and therapeutic potential.

Frontiers in immunology
2025

Enhancing the structural stability of P29-targeted monoclonal antibodies via β-hydroxybutyrylation modification improves their therapeutic performance in alveolar echinococcosis.

Frontiers in cellular and infection microbiology
2026

Diagnostic performance comparison of two ultrasound classification systems for hepatic alveolar echinococcosis: a single-center retrospective study.

Infectious diseases of poverty
2026

Crystal structure of Echinococcus multilocularis cystatin B reveals a novel feature in classical stefins.

Scientific reports
2026

First report of Taenia arctos (Cestoda: Taeniidae) from brown bears (Ursus arctos) in Romania.

Parasites &amp; vectors
2025

Corrigendum to "Chasing intermediate hosts of Echinococcus multilocularis at the southern edge of its European distribution using red fox stomach content analysis" [Int. J. Parasitol. Parasite. Wildlife 27 (2025) 101095].

International journal for parasitology. Parasites and wildlife
2026

International multicentre study to validate the Segmental Sedimentation and Counting Technique (SSCT) for the surveillance of Echinococcus multilocularis in red fox.

Veterinary parasitology
2025

Unmasking the mimic: vertebral alveolar echinococcosis diagnosed by metagenomic next-generation sequencing.

Infection
2025

TPEDCC-PEG-based photodynamic therapy exhibits potent therapeutic efficacy against echinococcosis by inducing oxidative stress and mitochondria-mediated apoptosis.

PLoS neglected tropical diseases
2025

Epidemiology and spatiotemporal patterns of human echinococcosis in China, 2006-2020.

Journal of helminthology
2025

A retrospective study on the efficacy of ex vivo liver resection combined with autologous liver transplantation in treating advanced alveolar echinococcosis at high altitude.

BMC gastroenterology
2025

Ex vivo liver resection and autotransplantation for hepatic alveolar echinococcosis with cavernous transformation of the portal vein.

Hepatobiliary &amp; pancreatic diseases international : HBPD INT
2025

Macroscopic and Microscopic Aspects of Echinococcus multilocularis and Echinococcus granulosus in Humans: A Guideline for Pathologists.

Visceral medicine
2025

Transcriptomic Profiling of mRNAs, circRNAs, and lncRNAs in Mouse Liver at the Early Stage of Echinococcus multilocularis Infection.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2025

Updating Clinical Management of Cystic and Alveolar Echinococcosis: Insights and Challenges.

Visceral medicine
2025

Clinical, Diagnostical, and Epidemiological Findings at First Diagnosis of Alveolar Echinococcosis: A Single-Center Cohort Study.

Visceral medicine
2025

Sectional Imaging for Alveolar Echinococcosis.

Visceral medicine
2025

[The infectious liver tumour].

Praxis
2025

Prioritizing interventions for echinococcosis prevention in China: a population attributable fraction analysis.

The Lancet regional health. Western Pacific
2025

The impact of radical hepatectomy on prognosis of patients with hepatic alveolar echinococcosis complicated with microvascular invasion.

Scientific reports
2025

Host angiogenic reprogramming by Echinococcus multilocularis protoscoleces protein via PDGFR/PI3K/AKT cascade.

Frontiers in microbiology
2025

Ultrasound-based population survey for abdominal cystic echinococcosis in Albania: Results from the NDTND project.

PLoS neglected tropical diseases
2026

Diagnosis of hepatic alveolar echinococcosis:18F-FDG-PET activity compared to the Echinococcus multilocularis Ulm Ultrasound Classification.

Nuklearmedizin. Nuclear medicine
2025

Mitochondrial Network Fragmentation Leads to Dysfunction of Macrophages During Echinococcus multilocularis Protoscoleces Infection.

Pathogens (Basel, Switzerland)
2025

Sonographic double patterns in hepatic alveolar echinococcosis according to the echinococcosis multilocularis ultrasound classification.

Parasitology research
2025

Is a shortened postoperative albendazole duration after curative surgery for alveolar echinococcosis possible? Results from a prospective multicenter study.

Parasites &amp; vectors
2025

In Vivo MicroRNA-Based Inhibition of Experimental Cestode Infection.

ACS infectious diseases
2025

Osteopontin Promotes Liver Echinococcus multilocularis Growth and Invasion via p38MAPK Pathway.

Parasite immunology
2025

Hepatic alveolar echinococcosis: a great tumor mimicker.

Diagnostic and interventional radiology (Ankara, Turkey)
2025

Investigation of the Alterations in the Gut Microbiota and Intestinal Mucosa in Mice Infected with Echinococcus multilocularis.

Acta parasitologica
2025

An oral M-cell targeted Lactococcus lactis vaccine against Echinococcus multilocularis infection.

Frontiers in immunology
2025

Effects of Abrus cantoniensis capsule on gut microbiota and intestinal barrier in mice infected with alveolar echinococcosis.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2025

Analysis of four Echinococcus multilocularis mitogenome sequences from Inner Mongolia, China: supporting the hypothesis that E. sibiricensis is confirmed as the O1 haplotype.

Parasites &amp; vectors
2026

Basal meningitis in a patient with hepatic alveolar echinococcosis.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2025

The Great Pretender: Echinococcal Infections Posing as Liver Cancer - Two Case Reports.

Case reports in oncology
2025

Profile of Cytokines TNFα, IL-1β, IL-6, IL-4, and IL-10 in Relation to Disease Progression in a Patient with Advanced Liver Alveolar Echinococcosis and Non-Optimal Antiparasitic Treatment: Four-Year Follow-Up.

Pathogens (Basel, Switzerland)
2025

Oxymatrine alleviates Echinococcus multilocularis infection by remodeling the liver immune microenvironment and intestinal flora homeostasis.

Frontiers in cellular and infection microbiology
2025

MicroRNA expression dynamics in mouse liver at different stages of Echinococcus multilocularis infection.

BMC genomics
2025

Hepatobiliary alveolar echinococcosis treated with delayed resection following percutaneous drainage.

Annals of hepato-biliary-pancreatic surgery
2025

Targeted inhibition of METTL3 reprograms alveolar echinococcosis progression: attenuating ferroptosis by downregulating ACSL4 and reversing macrophage M2 polarization.

International immunopharmacology
2025

Genetic diversity of Echinococcus multilocularis from red foxes and humans in northern and northeastern Poland investigated using the microsatellite EmsB.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
2025

Clinical application value of droplet digital PCR detection of Em-cfDNA in the diagnosis of hepatic alveolar echinococcosis.

Travel medicine and infectious disease
2025

The Role of Interventional Radiology for the Treatment of Liver CE and AE Lesions: Current Concepts.

Visceral medicine
2026

Whole-body dynamic FDG-PET/CT parametric imaging in alveolar echinococcosis.

Annals of nuclear medicine
2025

Human alveolar echinococcosis: consequences of discontinuation of albendazole treatment - a report of two cases.

Przeglad epidemiologiczny
2025

The incidence rates of human and animal echinococcosis: A systematic review.

Open veterinary journal
2025

Identification of key factors and explainability analysis for surgical decision-making in hepatic alveolar echinococcosis assisted by machine learning.

World journal of gastroenterology
2025

Two Decades of Living with Echinococcus multilocularis: A Clinical Epidemiology Study on Human Alveolar Echinococcosis in Hungary.

Infectious diseases and therapy
2025

Pulmonary malignant tumor metastasis or alveolar echinococcosis metastasis: the radiological dilemma.

Indian journal of thoracic and cardiovascular surgery
2025

Alveolar Echinococcosis Mimicking Perihilar Cholangiocarcinoma Leading to Liver Transplant: A Case Report.

The American journal of case reports
2025

Unexplained subcutaneous swelling: Keep echinococcosis in mind! Report of two primary extrahepatic subcutaneous echinococcosis cases and literature review.

PLoS neglected tropical diseases
2025

Heterotopic Auxiliary Liver Transplantation in a Child with Portal Hypertension Using a Discarded Partial Right Liver Allograft from an Adult Patient with Alveolar Echinococcosis.

Journal of clinical and translational hepatology
2025

Changing distribution, diversity, and health impact of Echinococcus multilocularis in Europe and North America: Comparison, connections, and opportunities.

Advances in parasitology
2025

Efferocytosis-Driven M2 Macrophage Impairs Fibrotic Encapsulation and Promotes Echinococcus multilocularis Growth in Cotton Rats (Sigmodon hispidus).

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada
2025

In vitro screening of the open-access Pandemic Response Box reveals ESI-09 as a compound with activity against Echinococcus multilocularis.

International journal for parasitology. Drugs and drug resistance
2025

Epidemiology and clinical characteristics of alveolar echinococcosis in India: A systematic review and individual participant data meta-analysis.

Indian journal of medical microbiology
2025

Epidemiological and clinical characteristics of patients in the alveolar echinococcosis registry, France, 1982 to 2021.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
2025

Alveolar echinococcosis of the adrenal gland: a rare diagnostic challenge among adrenal incidentalomas.

Polish archives of internal medicine
2025

An update on the prevalence of Echinococcus multilocularis in red foxes (Vulpes vulpes) in a Central European focus: Northern and northeastern Poland (2022-2024).

One health (Amsterdam, Netherlands)
2025

Community risk of environmental-borne cystic echinococcosis transmission in South America: Results from the multistep cross-sectional and case-control PERITAS study.

PLoS neglected tropical diseases
2025

Spatiotemporal distribution of newly diagnosed echinococcosis patients in Sichuan Province, China, 2013-2024.

PLoS neglected tropical diseases
2025

Blocking NKG2A in Echinococcus multilocularis infection partially relieves impairment of NK cell function of the host.

Cellular and molecular life sciences : CMLS
2025

Transcriptomic Profiling Reveals Gene Expression Changes in Mouse Liver Tissue During Alveolar Echinococcosis.

Genes
2025

Reappraisal of the impact of resection margin on outcomes after hepatectomy and perioperative treatment for Alveolar echinococcosis a single center experience.

HPB : the official journal of the International Hepato Pancreato Biliary Association
2025

Clinical confirmation of an infection with Echinococcus multilocularis (Mongolian genotype): first case report of human alveolar echinococcosis in Inner Mongolia, China.

Infectious diseases of poverty
2025

Comparative proteomic analysis of subcutaneous and intraperitoneal cysts of Echinococcus multilocularis.

Journal of proteomics
2025

A high-throughput LC-MS/MS method for simultaneous analysis of albendazole, albendazole sulfoxide and albendazole sulfone in human plasma.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2025

Acute peritoneal propagation of alveolar echinococcosis in a 12-year-old child.

Acta microbiologica et immunologica Hungarica
2025

Seasonal population dynamics and dietary switching of Vulpes spp. amplify Echinococcus spp. transmission in the Eastern Tibetan plateau: implications for wildlife-mediated zoonotic risks.

BMC veterinary research
2025

Echinococcosis on the Tibetan Plateau, where to go?

Trends in parasitology
2025

The initial stage of alveolar echinococcosis is a diagnostic challenge: a case report.

Journal of medical case reports
2025

CD155 as a therapeutic target in alveolar echinococcosis: insights from an Echinococcus multilocularis infection mouse model.

Frontiers in microbiology
2025

First molecular confirmed patient of alveolar echinococcosis in India: Case report from a tertiary care hospital in North India.

Indian journal of medical microbiology
2025

TIM4+macrophages suppress the proinflammatory response to maintain the chronic alveolar echinococcosis infection.

Frontiers in cellular and infection microbiology
2025

Chasing intermediate hosts of Echinococcus multilocularis at the southern edge of its European distribution using red fox stomach content analysis.

International journal for parasitology. Parasites and wildlife
2025

Parasite diversity in grey wolves (Canis lupus) from Tuscany, central Italy: a copromicroscopical investigation.

International journal for parasitology. Parasites and wildlife
2025

Molecular survey of taeniid cestodes with special emphasis on Echinococcus species in free-roaming dogs and wild carnivores in Armenia.

Parasitology
2025

IDO1 promotes Echinococcus multilocularis infection by regulating the formation of neutrophil extracellular traps.

Veterinary research
2025

Simultaneous combined surgery for hepatic-renal double organ alveolar or cystic echinococcosis: A retrospective study.

World journal of gastrointestinal surgery
2025

First detection of Echinococcus multilocularis in golden jackals (Canis aureus) in Bosnia and Herzegovina.

International journal for parasitology. Parasites and wildlife
2026

Unveiling the incidences and trends of alveolar echinococcosis in Europe: a systematic review from the KNOW-PATH project.

The Lancet. Infectious diseases
2025

Preliminary Proteomic and Metabolomic Analyses Reveal Potential Serum Biomarkers for Identifying Alveolar Echinococcosis in Mice.

Veterinary sciences
2025

EmsB Microsatellite Analysis of Echinococcus multilocularis Specimens Isolated from Belgian Patients with Alveolar Echinococcosis and from Animal Hosts.

Pathogens (Basel, Switzerland)
2025

First human infection and management of Versteria rafei infection restricted to the liver with phylogenetic analysis in the context of known cases.

The Lancet. Infectious diseases
2025

Settlement characteristics and transmission of echinococcosis: a cross-sectional study in nomadic communities on the Qinghai-Tibet Plateau, China.

Infectious diseases of poverty
2025

Activation of the Wnt signaling pathway and its role in epithelial-mesenchymal transition and hepatic fibrosis in alveolar echinococcosis.

Frontiers in cellular and infection microbiology
2025

Ultrasound Diagnostics in Alveolar Echinococcosis: An Update.

Visceral medicine
2025

Alveolar Echinococcosis in 11-Month-Old Dog-Clinical Case.

Pathogens (Basel, Switzerland)
2025

[Proportions of memory T cells and expression of their associated cytokines in lymph nodes of mice infected with Echinococcus multilocularis].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
2025

Hepatic alveolar echinococcosis infection induces a decrease in NK cell function through high expression of NKG2A in patients.

Frontiers in immunology
2025

Application of 11C-CHO in the imaging of cerebral alveolar echinococcosis: A prospective study.

Medicine
2025

Human alveolar echinococcosis lesion in the right atrium mimicking a large cardiac thrombus.

Polish archives of internal medicine
2025

The value of nomogram analysis in predicting pulmonary metastasis in hepatic alveolar echinococcosis.

Scientific reports
2026

Two-Stage Automatic Liver Classification System Based on Deep Learning Approach Using CT Images.

Journal of imaging informatics in medicine
2025

Minimally Invasive Surgical Strategies for Alveolar Echinococcosis of the Liver.

Visceral medicine
2025

Double Trouble on the Lower Leg-Unique Human Coinfection with Echinococcus granulosus and Echinococcus multilocularis Without Liver Involvement.

Pathogens (Basel, Switzerland)
2025

Echinococcus multilocularis Calreticulin Inhibits Lectin Pathway of Complement Activation by Directly Binding to Mannose-Binding Lectin.

Pathogens (Basel, Switzerland)
2025

Regulation of Host Regulatory T Cell Differentiation by emu-let-7-5p in Echinococcus multilocularis Infection Through Targeting NFκB2.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2025

[Infectious cysts and pseudocysts: When parasites want to mimic tumors!].

Annales de pathologie
2025

Corrigendum to "Identification and exploration of a new M2 macrophage marker MTLN in alveolar echinococcosis" [International Immunopharmacology 131 (2024) 111808].

International immunopharmacology
2025

Comprehensive Survival Analysis of Alveolar Echinococcosis Patients, University Hospital Zurich, Zurich, Switzerland, 1973-2022.

Emerging infectious diseases
2025

Hepatic alveolar echinococcosis with chest wall metastasis: a case report.

Frontiers in medicine
2025

Echinococcal Liver Infections: Comparing Transplant Strategies for Granulosus and Alveolaris.

Transplantation proceedings
2025

Alveolar echinococcosis in a patient diagnosed with liver tumor.

Polish archives of internal medicine
2025

Alveolar Echinococcosis: Is Non-Radical Liver Resection a Game Changer in the Current Treatment Approach to Patients with Advanced Alveolar Echinococcosis Disease? Single Center Experience of Poland.

Acta parasitologica
2025

Impact of Multimodal Fast-Track Protocols on Recovery in End-Stage Hepatic Alveolar Echinococcosis Patients Undergoing ex vivo Liver Resection and Autotransplantation: a Preliminary Study.

Infection and drug resistance
2025

Progress on the HIF-1α/VEGF/VEGFR2 signal pathway in hepatic alveolar echinococcosis.

Frontiers in oncology
2025

Zoonotic Echinococcus granulosus sensu lato genotypes G6 and G7: new insights from the global mitogenome analysis.

International journal for parasitology
2025

Host Proteins in Echinococcus multilocularis Metacestodes.

International journal of molecular sciences
2025

Ex vivo Liver Autotransplantation for Alveolar Echinococcosis with Brain and Lung Metastases: A Case Report.

International medical case reports journal
2025

Serum IgG galactosylation as a potential biomarker for the diagnosis of echinococcosis.

The Analyst
2025

Human Alveolar Echinococcosis-A Neglected Zoonotic Disease Requiring Urgent Attention.

International journal of molecular sciences
2025

Identification and characterization of the elusive protein backbone of the immuno-dominant and species-specific Em2(G11) metacestode antigen of Echinococcus multilocularis.

Frontiers in parasitology
2025

Inhibition of the MyD88/NF-κB pathway alters the Th1/Th2 balance to exacerbate liver injury and hepatic fibrosis in alveolar echinococcosis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2025

Current considerations for the management of liver echinococcosis.

World journal of gastroenterology
2025

Typing of Echinococcus multilocularis by Region-Specific Extraction and Next-Generation Sequencing of the mitogenome.

Frontiers in microbiology
2025

Advances in Novel Diagnostic Techniques for Alveolar Echinococcosis.

Diagnostics (Basel, Switzerland)
2025

Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of Echinococcus multilocularis and E. granulosus infections in dogs.

Parasites &amp; vectors
2025

CT-based radiomics models using intralesional and different perilesional signatures in predicting the microvascular density of hepatic alveolar echinococcosis.

BMC medical imaging
2025

Human alveolar echinococcosis-global, regional, and national annual incidence and prevalence rates.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
2025

Identifying KLF14 as a potential regulatory factor in liver regeneration trough transcriptomic and metabolomic.

Scientific reports
2025

Immunological landscape of hepatic alveolar echinococcosis: A bibliometric analysis.

World journal of hepatology
2025

New evidence from the northern Apennines, Italy, suggests a southward expansion of Echinococcus multilocularis range in Europe.

Scientific reports
2025

LncRNA gm40262 promotes liver fibrosis and parasite growth through the gm40262-miR-193b-5p-TLR4/Col1α1 axis.

mBio
2025

Spatiotemporal Transcriptomic Profiling Reveals the Dynamic Immunological Landscape of Alveolar Echinococcosis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2025

Alveolar echinococcosis in the canton of Geneva between 2010 and 2021: a descriptive analysis.

Swiss medical weekly
2025

Evaluation of the prevalence of Echinococcus multilocularis in free-roaming dogs in the human alveolar echinococcosis endemic region of Turkey.

Acta tropica
2025

Multimodal imaging for the diagnosis of cardiac alveolar echinococcosis: a case report.

BMC cardiovascular disorders
2025

Past, present and future epidemiology of echinococcosis in China based on nationwide surveillance data 2004-2022.

The Journal of infection
2025

The genetic variation of mitochondrial sequences and pathological differences of Echinococcus multilocularis strains from different continents.

Microbiology spectrum
2025

Efficacy and safety of pseudolaric acid B against Echinococcus multilocularis in vitro and in a murine infection model.

Frontiers in medicine
2025

Comparison of ultrasonographic features between two types of hepatic echinococcosis and hepatoblastoma in children.

Frontiers in pediatrics
2025

Dynamic evaluation of vertebral alveolar echinococcosis using MR T2 mapping.

Journal of orthopaedic surgery (Hong Kong)
2025

Correlation between imaging features and rEm18 antibodies in alveolar echinococcosis: results from a multicenter study in France.

Parasite (Paris, France)
2025

Risk factor analysis and prediction of multi-organ metastasis in hepatic alveolar echinococcosis.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
2025

A ticking time bomb? A position paper on the rising and neglected threat of alveolar echinococcosis in the Republic of Croatia.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
2025

Exploring the mechanism and drug candidates of alveolar echinococcosis affecting liver fibrosis through analysis of existing microarray data.

Acta tropica
2025

Expression of TNF-α, VEGF-A and Microvessel Density in Cerebral Alveolar Echinococcosis and Their Correlation with Perilesional Brain Edema.

Acta parasitologica
2025

Investigation of the threonine metabolism of Echinococcus multilocularis: The threonine dehydrogenase as a potential drug target in alveolar echinococcosis.

International journal for parasitology. Drugs and drug resistance
2025

Targeted Theranostic Nanoprobes Assisted In Vivo NIR-II Fluorescence Imaging-Guided Surgery Therapy for Alveolar Echinococcosis.

ACS applied materials &amp; interfaces
2025

Detection of Echinococcus spp. and other taeniid species in lettuces and berries: Two international multicenter studies from the MEmE project.

International journal of food microbiology
2024

The first case of alveolar echinococcosis from southern Croatia: progressive course of the disease in an immunocompromised patient.

Germs
2025

Combined two-step vascular exclusion and modified in situ hypothermic perfusion for advanced hepatic alveolar echinococcosis with cavernous transformation of portal vein (with video).

Hepatobiliary &amp; pancreatic diseases international : HBPD INT
2024

Inhibition of the MyD88 signaling pathway could upregulates Ghrelin expression to synergistically regulate hepatic Echinococcus multilocularis-infected progression.

Frontiers in immunology
2024

Insight into the history and trends of liver transplantation for echinococcosis: A bibliometric analysis.

World journal of hepatology
2024

Retrospective multidisciplinary analysis of human alveolar echinococcosis in Hungary using spatial epidemiology approaches.

Scientific reports
2024

Synergistic Effects of Anti-echinococcosis Drug Candidates Combined With Atovaquone in Culture Assays and Mice With Primary Infections of Echinococcus multilocularis.

Cureus
2024

Echinococcus granulosus sensu lato control measures: a specific focus on vaccines for both definitive and intermediate hosts.

Parasites &amp; vectors
2024

ECHINOCOCCUS MULTILOCULARIS IN NEW YORK WILDLIFE: DISTRIBUTION AND GENETIC DIVERSITY OF AN EMERGING PATHOGEN.

The Journal of parasitology
2025

Narrowing the region of candidate genes that control the development of protoscoleces of Echinococcus multilocularis in the mouse liver.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
2024

Risk factors associated with human echinococcosis: a systematic review and meta-analysis.

Frontiers in veterinary science
2025

A liver CT based nomogram to preoperatively predict lung metastasis secondary to hepatic alveolar echinococcosis.

European journal of radiology
2024

[Hepatic T cell subtypes and functional analysis among alveolar echinococcosis patients using single-cell RNA sequencing].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
2024

Expression and serodiagnostic efficacy of a novel echinococcosis-specific recombinant fusion antigen rAgB8/1-Em18-Eg95.

Parasitology
2024

Progress and perspectives on BMP9-ID1 activation of HIF-1α and VEGFA to promote angiogenesis in hepatic alveolar echinococcosis.

Frontiers in oncology
2025

Icterus provoked by Echinococcus mimicking a tumor: A diagnostic challenge.

Travel medicine and infectious disease
2024

Current status of drug therapy for alveolar echinococcosis.

World journal of hepatology
2025

Alveolar Echinococcosis - Diagnostic challenges of a parasitic disease on the rise in Europe - a case report.

Zeitschrift fur Gastroenterologie
2025

EchiNam: multicenter retrospective study on the experience, challenges, and pitfalls in the diagnosis and treatment of alveolar echinococcosis in Belgium.

European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology
2024

Upregulation of CD244 promotes CD8+ T cell exhaustion in patients with alveolar echinococcosis and a murine model.

Parasites &amp; vectors
2024

Ecological factors associated with fox feces density in an Echinococcus multilocularis endemic zone in Japan.

Frontiers in veterinary science
2024

Supersaturated drug delivery system of albendazole salt-polymer complex for improving oral bioavailability and efficacy anti-secondary E. multilocularis.

Acta tropica
2024

EX vivo liver resection and auto transplantation for a giant hepatocellular carcinoma: A case report.

International journal of surgery case reports
2024

Drug repurposing for hard-to-treat human alveolar echinococcosis: pyronaridine and beyond.

Parasitology
2024

Induced hepatocyte-like cells derived from adipose-derived stem cells alleviates liver injury in mice infected with Echinococcus Multilocularis.

Scientific reports
Ver todos os 1.294 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Equinococose alveolar.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Equinococose alveolar e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

A equinococose alveolar é provocada pela ingestão de ovos do parasita *Echinococcus multilocularis*. Não se trata de uma alteração genética, tendo herança classificada como não aplicável.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

10 publicações do grafo RarasNet (PubMed) · 5 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:284
    Orphanet
  2. GARD:207
    GARD (NIH)
  3. Q448768
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Equinococose alveolar. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/equinococose-alveolar

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Equinococose alveolar
Compêndio · Raras BR

Equinococose alveolar

ORPHA:284 · MONDO:0017282
Prevalência
Unknown
Herança
Not applicable
CID-10
B67.6 · Infecções por Echinococcus multilocularis, outras e de localizações múltiplas
CID-11
Início
Adult, Elderly
Prevalência
0.0 (Europe)
MedGen
UMLS
C0152069
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Rara